Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 3/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.36 |
| ▸ | NLN | Q9BYT8 | 2/20 | 0.35 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 3/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.35 |
| ▸ | HRH2 | P25021 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7421614 | 0.90 | F2 (0.43) | F2OPRK1OPRD1NLNAKR1C3 | |
| SCHEMBL7418561 | 0.85 | F2 (0.49) | F2OPRK1OPRD1NLNAKR1C3 | |
| SCHEMBL7417366 | 0.78 | F2 (0.37) | F2OPRK1OPRD1DPP4DPP8 | |
| Hydrochloric Acid SCHEMBL7417361 | 0.77 | F2 (0.36) | F2OPRK1OPRD1DPP4DPP8 | |
| Hydrochloric Acid SCHEMBL7417363 | 0.77 | F2 (0.36) | F2OPRK1OPRD1DPP4DPP8 | |
| SCHEMBL7443425 | 0.75 | F2 (0.54) | F2 | |
| SCHEMBL22669129 | 0.72 | HSD17B10 (0.40) | — | |
| SCHEMBL7435281 | 0.70 | OPRD1 (0.56) | F2OPRK1OPRD1NLNDPP4 | |
| SCHEMBL7359256 | 0.69 | F2 (0.53) | F2 | |
| SCHEMBL7360493 | 0.69 | F2 (0.53) | F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0815103-A1 | TRYPSIN AND THROMBIN INHIBITORS | Novartis AG (CH) | 1998-01-07 | — | — | EP | disclosed |
| WO-1996029327-A1 | TRYPSIN AND THROMBIN INHIBITORS | NOVARTIS AG (CH) | 1996-09-26 | — | — | WO | disclosed |